Aflibercept for clinically significant diabetic macular edema: 12-month results in daily clinical practice

QR Code

Aflibercept for clinically significant diabetic macular edema: 12-month results in daily clinical practice

Rafael Campos Polo, Consuelo Rubio Sánchez, Diego Manuel García Guisado, María José Díaz Luque Unit of Retina, Department of Ophthalmology, Hospital Virgen del Puerto, Plasencia, Cáceres, Spain Purpose: To assess the effectiveness a...

Full description

Saved in:

Bibliographic Details
Main Authors:	Campos Polo R, Rubio Sánchez C, Garcia Guisado DM, Díaz Luque MJ
Format:	article
Language:	EN
Published:	Dove Medical Press 2018
Subjects:	Aflibercept · Central macular thickness · Diabetic macular edema · Routine clinical practce · Visual acuity Ophthalmology RE1-994
Online Access:	https://doaj.org/article/6e34b3584c21494d9fee47e4d8372bf9
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Evaluation of contrast sensitivity and other visual function outcomes in diabetic macular edema patients following treatment switch to aflibercept from ranibizumab
by: Nixon DR, et al.
Published: (2018)

Contralateral eye-to-eye comparison of intravitreal ranibizumab and a sustained-release dexamethasone intravitreal implant in recalcitrant diabetic macular edema
by: Thomas BJ, et al.
Published: (2016)

Intravitreal aflibercept versus intravitreal ranibizumab for the treatment of diabetic macular edema
by: Fouda SM, et al.
Published: (2017)

Efficacy of Aflibercept versus Ranibizumab in the treatment of diabetic macular edema
by: Xiu-Xian Wang, et al.
Published: (2021)

Two Year Visual Acuity and Structural Outcomes in Patients with Diabetic Macular Oedema Treated with Intravitreal Aflibercept – A Retrospective Cohort Study
by: Kern C, et al.
Published: (2020)

One-Year Outcome of Aflibercept Intravitreal Injection in Vitrectomized Eyes with Diabetic Macular Edema
by: Tran THC, et al.
Published: (2021)

Intravitreal Ranibizumab or Aflibercept After Bevacizumab in Diabetic Macular Edema: Exploratory Retrospective Analysis
by: Pessoa B, et al.
Published: (2021)

Intravitreal ziv-aflibercept for macular edema following retinal vein occlusion
by: Paulose R, et al.
Published: (2016)

Intravitreal Aflibercept versus Laser Photocoagulation in Asian Patients with Diabetic Macular Edema: The VIVID-East Study
by: Chen YX, et al.
Published: (2020)

Relationship between aqueous humor cytokine level changes and retinal vascular changes after intravitreal aflibercept for diabetic macular edema
by: Rodolfo Mastropasqua, et al.
Published: (2018)

Role of aflibercept for macular edema following branch retinal vein occlusion: comparison of clinical trials
by: Oellers P, et al.
Published: (2016)

Prolongation of injection interval after switching therapy from ranibizumab to aflibercept in Japanese patients with macular edema secondary to branch retinal vein occlusion
by: Tagami M, et al.
Published: (2017)

Managing Diabetic Macular Edema in Clinical Practice: Systematic Review and Meta-Analysis of Current Strategies and Treatment Options
by: Veritti D, et al.
Published: (2021)

Aflibercept treatment for neovascular AMD beyond the first year: consensus recommendations by a UK expert roundtable panel, 2017 update
by: Patel PJ, et al.
Published: (2017)

Impact of Different Clinical Baseline Characteristics on Intravitreal Dexamethasone Implant Ozurdex® Outcomes
by: Udaondo P, et al.
Published: (2021)

Clinical Outcome and Drug Expenses of Intravitreal Therapy for Diabetic Macular Edema: A Retrospective Study in Sardinia, Italy
by: Chiara Altana, et al.
Published: (2021)

Intravitreal Tissue Plasminogen Activator Injection for Treatment-Resistant Diabetic Macular Edema of the Vitrectomized Eye
by: Ren Aoki, et al.
Published: (2021)

Effects of Intravitreous Aflibercept Injection in Pachychoroid Neovasculopathy: Comparison with Typical Neovascular Age-Related Macular Degeneration
by: Elfandi S, et al.
Published: (2021)

Real-World Outcomes in Patients with Diabetic Macular Edema Treated Long Term with Ranibizumab (VISION Study)
by: Van Aken E, et al.
Published: (2020)

Subfoveal choroidal thickness in diabetic macular edema
by: Mohamed DM, et al.
Published: (2019)

Baseline visual acuity strongly predicts visual acuity gain in patients with diabetic macular edema following anti-vascular endothelial growth factor treatment across trials
by: Dugel PU, et al.
Published: (2016)

Pseudophakic cystoid macular edema: update 2016
by: Grzybowski A, et al.
Published: (2016)

EFFECT OF INTRAVITREAL TRIAMCINOLONE ACETONIDE IN REFRACTORY DIABETIC MACULAR EDEMA
by: Ume Sughra, et al.
Published: (2021)

Effectiveness and Safety of the Clareon Monofocal Intraocular Lens: Outcomes from a 12-Month Single-Arm Clinical Study in a Large Sample
by: Lehmann R, et al.
Published: (2021)

Short-term outcomes in patients with branch retinal vein occlusion who received intravitreal aflibercept with or without intravitreal ranibizumab
by: Sakanishi Y, et al.
Published: (2017)

Baseline Subfoveal Choroidal Thickness as a Predictor for Response to Short-Term Intravitreal Bevacizumab Injections in Diabetic Macular Edema
by: Dweikat A, et al.
Published: (2021)

Intravitreal aflibercept for exudative age-related macular degeneration with good visual acuity: 2-year results of a prospective study
by: Sakamoto S, et al.
Published: (2018)

EFFECT OF ANTI-VEGF THERAPY ON THE STRUCTURAL STATE OF THE RETINA IN DIABETIC MACULAR EDEMA
by: M. M. Bikbov, et al.
Published: (2016)

Early Conversion to Aflibercept for Persistent Diabetic Macular Edema Results in Better Visual Outcomes and Lower Treatment Costs
by: Ramsey DJ, et al.
Published: (2021)

Treatment of Macular Edema in Vascular Retinal Diseases: A 2021 Update
by: Andrzej Grzybowski, et al.
Published: (2021)

Effect of oral tranexamic acid on macular edema associated with retinal vein occlusion or diabetes
by: Takeyama M, et al.
Published: (2017)

Rebound macular edema following oral acetazolamide therapy for juvenile X-linked retinoschisis in an Italian family
by: Galantuomo MS, et al.
Published: (2016)

Multicenter, Prospective, Randomized Study of Dexamethasone Intravitreal Implant in Patients with Center-Involved Diabetic Macular Edema in the Asia-Pacific Region
by: Wei W, et al.
Published: (2021)

Primary treatment of diabetic macular edema
by: Tushar M Ranchod, et al.
Published: (2009)

CHOROIDAL THICKNESS IN PATIENTS WITH DIABETIC MACULAR EDEMA
by: Amash Aqil, et al.
Published: (2021)

Switching to aflibercept among patients with treatment-resistant neovascular age-related macular degeneration: a systematic review with meta-analysis
by: Spooner K, et al.
Published: (2017)

Diagnostic Criteria for Macular Edema Associated with Venous Occlusions
by: A. G. Shchuko, et al.
Published: (2020)

The 2-Year Leakage Index and Quantitative Microaneurysm Results of the RECOVERY Study: Quantitative Ultra-Widefield Findings in Proliferative Diabetic Retinopathy Treated with Intravitreal Aflibercept
by: Amy S. Babiuch, et al.
Published: (2021)

Five-year outcomes of intravitreal drug therapy for neovascular age-related macular degeneration in eyes with baseline vision 20/60 or better
by: Khanani AM, et al.
Published: (2019)

Intravitreal pegaptanib for the treatment of ischemic diabetic macular edema
by: Kiire CA, et al.
Published: (2015)